Skip to main content

Table 1 Baseline characteristics and Correlation analysis for clinicopathologic variables between EIF4A2-low and EIF4A2-high groups of 297 CRC patients

From: Eukaryotic initiation factor 4A2 promotes experimental metastasis and oxaliplatin resistance in colorectal cancer

Variable

Total (%)

low EIF4A2

n (%)

high EIF4A2

n (%)

P value

Total

297 (100)

172 (57.9)

125 (42.1)

 

Age, years

   

0.557

  >  57

137(46.1)

82 (47.7)

55 (44.0)

 

  ≤ 57

160(53.9)

90 (52.3)

70 (56.0)

 

Gender

   

0.469

 male

185 (62.3)

104 (60.5)

81 (64.8)

 

 female

112(37.7)

68 (39.5)

44 (35.2)

 

Lymph node metastasis

   

0.184

 N0–1

218(73.4)

121 (69.2)

97 (77.6)

 

 N2

79(26.6)

51 (30.8)

28 (22.4)

 

Nerve invasion

   

0.078

 No

152 (51.2)

96 (55.8)

56 (44.8)

 

 Yes

145 (48.8)

76 (44.2)

69 (55.2)

 

Invasion depth

   

0.115

 No whole layer

29 (9.8)

21 (12.2)

8 (6.4)

 

 Whole layer

268 (90.2)

151 (87.8)

117 (93.6)

 

Vascular thrombosis

   

0.252

 No

206 (69.4)

124 (72.1)

82 (65.6)

 

 Yes

91 (30.6)

48 (27.9)

43 (34.4)

 

Metastasis status

   

0.031

 No

245 (82.5)

149 (86.6)

96 (76.8)

 

 Yes

52 (17.5)

23 (13.4)

29 (23.2)

 

Degree of differentiation

   

0.674

 Well and moderately differentiated

230 (77.4)

135 (78.5)

95 (76.0)

 

 Poorly differentiated

67 (22.6)

37 (21.5)

30 (24.0)

 

TNM stage

   

0.003

 I

20 (6.7)

12 (7.0)

8 (6.4)

 

 II

87 (29.3)

42 (24.4)

45 (36.0)

 

 III

138 (46.5)

95 (55.2)

43 (34.4)

 

 IV

52 (17.5)

23 (13.4)

29 (23.2)

Â